2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Leukemia, Myeloid, Acute
124
Multiple Myeloma
84
Precursor Cell Lymphoblastic Leukemia-Lymphoma
76
Lymphoma
73
Lymphoma, Non-Hodgkin
66
Leukemia
66
Myelodysplastic Syndromes
56
Hodgkin Disease
53
Lymphoma, Large B-Cell, Diffuse
37
Lymphoma, Mantle-Cell
33
Breast Neoplasms
32
Neuroblastoma
30
Leukemia, Lymphocytic, Chronic, B-Cell
30
Burkitt Lymphoma
30
Lymphoma, Follicular
26
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
26
Recurrence
24
Sarcoma
18
Neoplasms, Plasma Cell
18
Hematologic Neoplasms
18
Central Nervous System Neoplasms
18
Lymphoma, B-Cell, Marginal Zone
17
Leukemia, Biphenotypic, Acute
16
Myeloproliferative Disorders
15
Lymphoma, Large-Cell, Immunoblastic
15
Congenital Abnormalities
15
Brain Neoplasms
14
Leukemia, Myelomonocytic, Chronic
13
Anemia, Refractory, with Excess of Blasts
13
Medulloblastoma
12
Interventions
Rituximab
10
Valganciclovir
6
Etoposide
4
Doxorubicin
4
Valacyclovir
3
Gemcitabine
3
Dexamethasone
3
Cyclophosphamide
3
Cisplatin
3
spartalizumab
2
pembrolizumab
2
pegaspargase
2
Zidovudine
2
Vincristine
2
Radiotherapy, Intensity-Modulated
2
Prednisone
2
Methylprednisolone
2
Methotrexate
2
Matrix-M
2
Leucovorin
2
Lenalidomide
2
Cell Count
2
Carboplatin
2
Blood Specimen Collection
2
Acyclovir
2
valomaciclovir
1
toripalimab
1
threonic acid
1
ruxolitinib
1
pomalidomide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Epstein-Barr Virus Infections
×
Granulocyte Colony-Stimulating Factor
×
Clear all
NCT00953420
2017-08-18
CADEN
Baylor College of Medicine
Phase 2
Completed
20 enrolled